{"href":"https://api.simplecast.com/oembed?url=https%3A%2F%2Famindr.com%2Fepisodes%2F48-preclinical-testing-part-3-alzheimers-disease-august-2020-UKs3vrvM","width":444,"version":"1.0","type":"rich","title":"48 - Preclinical Testing Part 3: Alzheimer's Disease August 2020","thumbnail_width":300,"thumbnail_url":"https://image.simplecastcdn.com/images/9a8ef428-72db-47cb-a5cb-a6a258a13785/21ef6f98-5785-49e5-971a-8b88292d526f/slide37.jpg","thumbnail_height":300,"provider_url":"https://simplecast.com","provider_name":"Simplecast","html":"<iframe src=\"https://player.simplecast.com/37c89aee-5621-4be3-a64c-c8168e8cb83c\" height=\"200\" width=\"100%\" title=\"48 - Preclinical Testing Part 3: Alzheimer&apos;s Disease August 2020\" frameborder=\"0\" scrolling=\"no\"></iframe>","height":200,"description":"Join Anusha as she dives into papers published from August of 2020 that uncovers the effects of potential therapeutics in animal models for Alzheimer's Disease. In the first section, she covers research that targets multiple aspects of Alzheimer's pathology. In the second section, she focuses on research that aims to improve cognition and memory in animal models. "}